Tip Sheet: Johns Hopkins Researchers Present at Annual CROI Meeting

Date: 03/01/2018

A5279 and P1078 are referenced in this press release from Johns Hopkins Medicine.

Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...

IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...